Pathways Mutual Gaze Protocol for Autism
Trial Summary
What is the purpose of this trial?
Purpose of the Study: The goal of this clinical trial is to find out if a technique called the "mutual gaze procedure," used in Pathways Early Intervention (Pathways), is the key to helping improve social communication, language, and everyday skills in young children (16-30 months old) who are at high risk for autism, particularly those from diverse cultural and language backgrounds. What Will Happen: Researchers will compare two versions of the Pathways Intervention: * Version 1: Includes mutual gaze strategies. * Version 2: Does not include mutual gaze strategies. What to Expect: Participants will: * Attend 12 sessions of Pathways Intervention, each lasting 1.5 hours (or 15 weeks if there are cancellations). * Come to the clinic for a developmental check-up three times: before starting Pathways, right after completing Pathways, and three months after finishing Pathways.
Do I need to stop my child's current medications for this trial?
The trial protocol does not specify whether participants must stop taking current medications.
What data supports the idea that Pathways Mutual Gaze Protocol for Autism is an effective treatment?
The available research does not provide any specific data or evidence supporting the effectiveness of the Pathways Mutual Gaze Protocol for Autism. The studies mentioned focus on early intervention for psychosis, traumatic brain injury management, and pathways to mental health care, but none of them address the Pathways Mutual Gaze Protocol or its impact on autism. Therefore, there is no data in the provided information to support the effectiveness of this treatment for autism.12345
What safety data is available for the Pathways Mutual Gaze Protocol for Autism?
The provided research does not specifically mention safety data for the Pathways Mutual Gaze Protocol or its related interventions. However, it highlights the importance of monitoring and reporting adverse events in pediatric psychosocial interventions. The need for comprehensive assessment and reporting of adverse events is emphasized to ensure the safety and effectiveness of psychological treatments for children. This suggests that while specific safety data for the Pathways interventions may not be available, there is a recognized need for such data in similar interventions.678910
Is Pathways Parent Mediated Intervention a promising treatment for autism?
Research Team
Pamela Rollins, EdD
Principal Investigator
University of Texas at Dallas
Eligibility Criteria
This trial is for young children aged 16-30 months who are at high risk for autism and have social challenges, with parents fluent in English. It's aimed at those living within 30 miles of the Callier Center Dallas without other neurological or genetic disorders.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 12 sessions of Pathways Intervention, each lasting 1.5 hours, over approximately 15 weeks
Post-Intervention Assessment
Participants undergo assessments to evaluate the immediate effects of the intervention
Follow-up
Participants are monitored for long-term effects of the intervention, including social communication and adaptive functioning
Treatment Details
Interventions
- Pathways Parent Mediated Intervention
- Pathways Parent Mediated Intervention without Mutual Gaze
Pathways Parent Mediated Intervention is already approved in United States for the following indications:
- Improvement of social communication skills in young children suspected of autism
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas at Dallas
Lead Sponsor
Texas Higher Education Coordinating Board
Collaborator